Report cover image

Diagnostic Biomarkers Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385716

Description

Diagnostic Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostic biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for diagnostic biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: Safety Biomarkers; Efficacy Biomarkers; Validation Biomarkers

2) By Application: Oncology; Metabolic Disease; Neurological Disease

3) By End User: Hospitals; Cancer Research Institutes; Diagnostic Labs

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers; Organ-Specific Safety Biomarkers; Drug-Induced Injury Biomarkers

2) By Efficacy Biomarkers: Predictive Biomarkers; Prognostic Biomarkers; Pharmacodynamic Biomarkers

3) By Validation Biomarkers: Genomic Biomarkers; Proteomic Biomarkers; Metabolomic Biomarkers

Companies Mentioned: Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; PerkinElmer Inc.; Siemens Healthineers AG; Merck KGaA; Agilent Technologies Inc.; Charles River Laboratories International Inc.; Bio-Rad Laboratories Inc.; Bruker Corporation; Qiagen N.V.; Myriad Genetics Inc.; Meso Scale Diagnostics LLC; EKF Diagnostics Holdings Plc; Sino Biological Inc.; Enzo Biochem Inc.; Biomarker Technologies Inc.; Cisbio Bioassays; Signosis Inc.; Epigenomics AG; LifeSign LLC; Banyan Biomarkers Inc.; Biosims Technologies SAS

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Corneal Endothelial Dystrophy Market Characteristics
3. Corneal Endothelial Dystrophy Market Trends And Strategies
4. Corneal Endothelial Dystrophy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Corneal Endothelial Dystrophy Growth Analysis And Strategic Analysis Framework
5.1. Global Corneal Endothelial Dystrophy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Corneal Endothelial Dystrophy Market Growth Rate Analysis
5.4. Global Corneal Endothelial Dystrophy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Corneal Endothelial Dystrophy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Corneal Endothelial Dystrophy Total Addressable Market (TAM)
6. Corneal Endothelial Dystrophy Market Segmentation
6.1. Global Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phototherapeutic Keratectomy
Amniotic Membrane Transplants
Anterior Stromal Puncture
Conjunctival Flaps
6.2. Global Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Congenital Hereditary Endothelial Dystrophy 1
Congenital Hereditary Endothelial Dystrophy 2
Posterior Polymorphous Corneal Dystrophy
Fuchs Endothelial Corneal Dystrophy
6.3. Global Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cornea Examination And Grading
Corneal Tomography
Corneal Pachymetry
Corneal Cell Count
6.4. Global Corneal Endothelial Dystrophy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other End Users
6.5. Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Phototherapeutic Keratectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Excimer Laser Therapy
Corneal Reshaping
6.6. Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Amniotic Membrane Transplants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fresh Amniotic Membrane Transplant
Cryopreserved Amniotic Membrane Transplant
6.7. Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Anterior Stromal Puncture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Manual Technique
Laser-Assisted Technique
6.8. Global Corneal Endothelial Dystrophy Market, Sub-Segmentation Of Conjunctival Flaps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Partial Flap Technique
Full Flap Technique
7. Corneal Endothelial Dystrophy Market Regional And Country Analysis
7.1. Global Corneal Endothelial Dystrophy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Corneal Endothelial Dystrophy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Corneal Endothelial Dystrophy Market
8.1. Asia-Pacific Corneal Endothelial Dystrophy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Corneal Endothelial Dystrophy Market
9.1. China Corneal Endothelial Dystrophy Market Overview
9.2. China Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Corneal Endothelial Dystrophy Market
10.1. India Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Corneal Endothelial Dystrophy Market
11.1. Japan Corneal Endothelial Dystrophy Market Overview
11.2. Japan Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Corneal Endothelial Dystrophy Market
12.1. Australia Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Corneal Endothelial Dystrophy Market
13.1. Indonesia Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Corneal Endothelial Dystrophy Market
14.1. South Korea Corneal Endothelial Dystrophy Market Overview
14.2. South Korea Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Corneal Endothelial Dystrophy Market
15.1. Western Europe Corneal Endothelial Dystrophy Market Overview
15.2. Western Europe Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Corneal Endothelial Dystrophy Market
16.1. UK Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Corneal Endothelial Dystrophy Market
17.1. Germany Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Corneal Endothelial Dystrophy Market
18.1. France Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Corneal Endothelial Dystrophy Market
19.1. Italy Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Corneal Endothelial Dystrophy Market
20.1. Spain Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Corneal Endothelial Dystrophy Market
21.1. Eastern Europe Corneal Endothelial Dystrophy Market Overview
21.2. Eastern Europe Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Corneal Endothelial Dystrophy Market
22.1. Russia Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Corneal Endothelial Dystrophy Market
23.1. North America Corneal Endothelial Dystrophy Market Overview
23.2. North America Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Corneal Endothelial Dystrophy Market
24.1. USA Corneal Endothelial Dystrophy Market Overview
24.2. USA Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Corneal Endothelial Dystrophy Market
25.1. Canada Corneal Endothelial Dystrophy Market Overview
25.2. Canada Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Corneal Endothelial Dystrophy Market
26.1. South America Corneal Endothelial Dystrophy Market Overview
26.2. South America Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Corneal Endothelial Dystrophy Market
27.1. Brazil Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Corneal Endothelial Dystrophy Market
28.1. Middle East Corneal Endothelial Dystrophy Market Overview
28.2. Middle East Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Corneal Endothelial Dystrophy Market
29.1. Africa Corneal Endothelial Dystrophy Market Overview
29.2. Africa Corneal Endothelial Dystrophy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Corneal Endothelial Dystrophy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Corneal Endothelial Dystrophy Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Corneal Endothelial Dystrophy Market Competitive Landscape And Company Profiles
30.1. Corneal Endothelial Dystrophy Market Competitive Landscape
30.2. Corneal Endothelial Dystrophy Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Abbvie (Allergan plc) Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Corneal Endothelial Dystrophy Market Other Major And Innovative Companies
31.1. Bausch Health+Lomb
31.2. Santen Pharmaceutical Co., Ltd.
31.3. AGC Biologics Inc
31.4. Lumenis Ltd
31.5. Aurion Biotech Inc
31.6. Carl Zeiss Meditec AG
31.7. Keeler Limited
31.8. Kowa Company Ltd.
31.9. ProQR Therapeutics N.V.
31.10. Cellusion Inc.
31.11. OptoTech GmbH
31.12. ActualEyes Inc.
31.13. Arctic Vision Inc.
31.14. Aurion Biotech LLC
31.15. Emmecell S.R.L
32. Global Corneal Endothelial Dystrophy Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Corneal Endothelial Dystrophy Market
34. Recent Developments In The Corneal Endothelial Dystrophy Market
35. Corneal Endothelial Dystrophy Market High Potential Countries, Segments and Strategies
35.1 Corneal Endothelial Dystrophy Market In 2029 - Countries Offering Most New Opportunities
35.2 Corneal Endothelial Dystrophy Market In 2029 - Segments Offering Most New Opportunities
35.3 Corneal Endothelial Dystrophy Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.